November 4, 2021
CDC recommends Pfizer/BioNTech pediatric COVID-19 vaccine
Editor's Note
The Centers for Disease Control and Prevention (CDC), on November 2, recommended broad use of the Pfizer/BioNTech COVID-19 vaccine for children ages 5 to 11.
Distribution of the vaccine to clinics, children’s hospitals, and pediatricians’ offices across the country have started, with plans to scale up to full capacity starting the week of November 8.
Free Daily News
- AI-driven CMS pilot model could slow ASC care despite fraud-fighting goals
- Governors form alliance to fill federal public health gaps amid cuts, shutdown
- UnitedHealthcare anesthesia cuts spark backlash over patient access risks
- Your playbook for OR wins is in Anaheim
- UCSF surgeons spotlight innovation, perioperative research at national surgical conference
- FDA recalls affect surgical staplers, OR procedure kits, ultrasound systems used in hospitals
- C-sections linked to longer recovery, higher pain, sleep problems for new mothers
- AI model grades nursing procedures with near-human precision
- Study: Hospitals can safely cut low-value preop tests before routine surgeries
- New studies highlight opportunities to improve pediatric anesthesia safety, comfort
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement